Demyelinating disease

Nerves in your brain and body are wrapped in a protective, fatty coating called myelin, which acts like the plastic insulation around an electrical wire to help signals travel fast and smooth. Many demyelinating diseases happen when your body's immune system mistakenly attacks and damages this coating. Without this insulation, your brain's internal communication slows down or gets blocked, causing a wide range of nerve issues.

Doctors group these conditions based on where and how the damage happens:

• Multiple sclerosis (MS): the most common form in adults, where the immune system repeatedly attacks myelin in the brain and spinal cord over time.

• Neuromyelitis optica spectrum disorder (NMOSD) and MOG antibody-associated disease (MOGAD): two specific autoimmune conditions that primarily target the eye nerves (causing vision changes) and the spinal cord.

• Clinically isolated syndrome (CIS): a single, first-time flare-up of nerve symptoms that hasn't yet developed into full MS.

• Transverse myelitis: sudden inflammation restricted entirely to the spinal cord, causing rapid leg weakness or numbness.

• Acute disseminated encephalomyelitis (ADEM): a brief, one-time wave of widespread brain inflammation that usually happens after a common virus or vaccine, mostly in children.

Demyelinating disease symptoms depend on which areas of the nervous system are affected. They often develop over hours to days, may partially or fully resolve, and can recur. Common presentations include:

• Visual disturbances, particularly optic neuritis causing painful loss of vision in one eye, reduced colour vision, or blurred vision

• Tingling, numbness, or a band-like tightness around the trunk or limbs

• Weakness in one or more limbs, ranging from mild heaviness to significant functional impairment

• Balance and coordination problems, unsteady gait, or dizziness

• Fatigue that is disproportionate to activity level and unlike normal tiredness

• Cognitive difficulties including memory, concentration, and processing speed

• Bladder urgency, frequency, or incomplete emptying

• Lhermitte's sign, an electric shock sensation running down the spine on neck flexion, indicating cervical spinal cord involvement

• Heat sensitivity, with symptoms temporarily worsening in warm conditions (Uhthoff's phenomenon)

Demyelinating diseases happen when the immune system gets confused and attacks the nervous system's protective coating. While the exact trigger isn't fully understood, common factors include:

• Immune confusion: in conditions like MS, the body mistakenly creates cells and proteins that target and destroy its own nerve insulation.

• Infections: viruses like Epstein-Barr (the virus that causes mono) are strongly linked to triggering MS, while other common infections can spark one-time inflammation like ADEM.

• Environment and lifestyle: low vitamin D levels, lack of sunlight (living further from the equator), and smoking all significantly increase the risk and speed up the damage.

• Genetics: carrying specific genes can make a person more vulnerable to developing these conditions.

Demyelinating disease is detected through brain and spinal cord MRI, with blood tests playing a critical role in identifying specific antibody markers that distinguish between conditions and exclude other causes of similar symptoms.

Brain and Spinal MRI Elfcare’s full-body MRI includes comprehensive brain imaging and cervical spine imaging as standard. It can identify demyelinating lesions and characterise their distribution, size, and signal characteristics, findings that can raise suspicion for MS or other demyelinating conditions, though specialist assessment is needed to distinguish between them.

Blood tests play a central role in differentiating between demyelinating conditions and excluding metabolic mimics. Relevant markers in Elfcare's panel include:

• Vitamin B12 and folate: rules out deficiencies that can cause spinal cord damage and mimic MS on an MRI.

• Homocysteine: high levels from vitamin deficiencies cause brain changes that overlap with demyelinating disease.

• Vitamin D: low levels are linked to a higher risk of MS and more severe nerve flare-ups.

• Thyroid panel (TSH, Free T3, Free T4): identifies thyroid imbalances that cause overlapping nerve symptoms.

• CRP: measures inflammation to help rule out active infections causing your symptoms.

• tTG-IgA: checks for gluten intolerance, which can cause nerve damage and balance issues that look like MS.

Why early detection matters

Early recognition and treatment of demyelinating diseases can help reduce disease activity and the risk of accumulating neurological disability. In multiple sclerosis (MS), disease-modifying therapies can be particularly beneficial when started early in appropriate patients, before substantial irreversible neurological damage has occurred.

A clinically isolated syndrome (CIS) may be an early presentation of MS. MRI findings can help assess the likelihood of further disease activity and guide decisions about monitoring and treatment. For people at higher risk of developing MS, early treatment may reduce the risk of further clinical episodes and delay progression to clinically definite MS.

For neuromyelitis optica spectrum disorder (NMOSD), early diagnosis is particularly important because attacks affecting the optic nerves or spinal cord can result in significant and sometimes permanent neurological disability. Prompt specialist assessment and appropriate preventive treatment can reduce the risk of future attacks.

How Elfcare can help

Elfcare's full body MRI includes brain and cervical spine imaging as standard, where applicable, allowing structural abnormalities and white-matter lesions that may be associated with demyelinating disease to be identified and characterised. Certain imaging patterns may raise suspicion for conditions such as multiple sclerosis (MS) or other demyelinating disorders, but MRI findings alone cannot establish a specific diagnosis.

Our blood panel includes markers such as vitamin B12, folate, vitamin D and thyroid-related tests that can provide additional clinical context when neurological symptoms or MRI findings require further investigation. Additional disease-specific testing may be required depending on the clinical presentation.

If our MRI or blood tests identify findings that may warrant investigation for demyelinating disease, we take care of further diagnostics or refer you to the appropriate specialist.